On the heterogeneity of murine natural killer cells.

Polarization of the Golgi apparatus and the microtubule-organizing center within cloned natural killer cells bound to their targets. Proc Natl Acad Sci U S A (1983) 2.85

Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes. J Clin Invest (1985) 2.77

Characteristics of natural killer cells in the murine intestinal epithelium and lamina propria. J Exp Med (1982) 2.12

The Thy-1-bearing cell of murine epidermis. A distinctive leukocyte perhaps related to natural killer cells. J Exp Med (1985) 1.93

Identification of a clonally restricted 90 kD heterodimer on two human cloned natural killer cell lines. Its role in cytotoxic effector function. J Exp Med (1983) 1.62

Transplantable progenitors of natural killer cells are distinct from those of T and B lymphocytes. Proc Natl Acad Sci U S A (1986) 1.54

Interleukin 2 enhances natural killer cell activity through induction of gamma interferon. Infect Immun (1983) 1.45

Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver. J Exp Med (1984) 1.41

A cloned cell line mediating natural killer cell function inhibits immunoglobulin secretion. J Exp Med (1982) 1.41

Analysis of natural killer effector and suppressor activity by intraepithelial lymphocytes from mouse small intestine. Clin Exp Immunol (1983) 1.18

Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus. J Clin Invest (1983) 1.09

The tumor microenvironment: a pitch for multiple players. Front Oncol (2013) 1.07

Expression and rearrangement of the alpha, beta, and gamma chain genes of the T cell receptor in cloned murine large granular lymphocyte lines. No correlation with the cytotoxic spectrum. J Exp Med (1986) 1.07

In vitro generated mast cells express natural cytotoxicity against tumour cells. Immunology (1985) 1.05

Expression of the NKTa clonotype in a series of human natural killer clones with identical cytotoxic specificity. J Exp Med (1986) 1.04

The activity of natural cytotoxic cells is augmented by interleukin 2 and interleukin 3. J Exp Med (1983) 1.02

Generation of continuous large granular lymphocyte lines by interleukin 2 from the spleen cells of mice infected with Moloney leukemia virus. Involvement of interleukin 3. J Exp Med (1987) 0.93

Natural killer cell recognition of target cells expressing different antigens of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1985) 0.91

Interleukin 2 and stimulator lymphoblastoid cells will induce human thymocytes to bind and kill K562 targets. J Exp Med (1982) 0.91

Deficient natural killer cell activity in alcoholic cirrhosis. Clin Exp Immunol (1984) 0.89

Interleukin-2-induced activation of natural killer activity in spleen cells from old and young mice. Immunology (1984) 0.88

Decreased tumorigenicity correlates with expression of altered cell surface carbohydrates in Lec9 CHO cells. Mol Cell Biol (1986) 0.88

Enhanced natural killer cell activity in experimental murine encephalitozoonosis. Infect Immun (1983) 0.86

Toxoplasma-induced activities of peritoneal and spleen natural killer cells from beige mice against thymocytes and YAC-1 lymphoma targets. Infect Immun (1984) 0.86

Interleukin-2 in vivo: production of and response to interleukin-2 in lymphoid organs undergoing a primary immune response to heterologous erythrocytes. Immunology (1985) 0.85

Interleukin 2 augmentation of natural killer cell activity in homosexual men with acquired immune deficiency syndrome. Infect Immun (1984) 0.85

Eradication of established human melanoma tumors in nude mice by antibody-directed effector cells. J Exp Med (1985) 0.84

Phenotype of cytotoxic effector cells infiltrating a transplanted, chemically induced rat sarcoma. Immunology (1984) 0.84

In vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. III. Spontaneous and natural cytotoxic effector cells. Immunology (1984) 0.84

Differentiation from precursors in athymic nude mouse bone marrow of unusual spontaneously cytolytic cells showing anti-self-H-2 specificity and bearing T cell markers. J Exp Med (1983) 0.83

Recognition and regulation of progenitor marrow elements by NK cells in the mouse. Immunology (1983) 0.82

Regulation of the growth and functions of cloned murine large granular lymphocyte lines by resident macrophages. J Exp Med (1985) 0.81

Spontaneous cytotoxic T cells in murine spleen-cell cultures. I. Some characteristics of effector and precursor cells. Immunology (1983) 0.80

Alloresistance to engraftment of allogeneic donor bone marrow is mediated by an Lyt-2+ T cell in mixed allogeneic reconstitution (C57BL/10Sn + B10.D2/nSn----C57BL/10Sn). J Exp Med (1986) 0.79

In vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. II. Separation of natural killer cells and cytotoxic T cells. Immunology (1984) 0.78

Regulation of natural and antibody-dependent cellular cytotoxicity by staphylococcal enterotoxin A. Clin Exp Immunol (1983) 0.78

"Anomalous" Thy-1+ killer cells in allogeneic and F1-anti-parental mixed leukocyte culture. Relation to natural killer cells and allospecific cytotoxic T lymphocytes. J Exp Med (1983) 0.77

Simultaneous development of cells with large granular lymphocyte (LGL) morphology and natural killer (NK) cell lytic activity after bone marrow (BM) transplantation in mice. Immunology (1988) 0.75

The in vitro generation and sustained culture of nude mouse cytolytic T-lymphocytes. J Exp Med (1979) 3.15

Specificity of cytotoxic T cells from athymic mice. J Exp Med (1980) 2.07

Natural cytotoxic cells against solid tumors in mice. I. Strain and age distribution and target cell susceptibility. J Immunol (1978) 2.06

Low density of Thy 1 antigen on mouse effector cells mediating natural cytotoxicity against tumor cells. J Immunol (1978) 2.04

The beige mutation in the mouse. II. Selectivity of the natural killer (NK) cell defect. J Immunol (1979) 2.02

Identification of a cell-surface antigen selectively expressed on the natural killer cell. J Exp Med (1977) 1.97

Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice. J Exp Med (1979) 1.81

Promonocytes have the functional characteristics of natural killer cells. J Immunol (1979) 1.80

Recycling and target binding capacity of human natural killer cells. J Exp Med (1981) 1.71

Mode of regulation of natural killer cell activity by interferon. J Exp Med (1980) 1.63

Influence of anti-mouse interferon serum on the growth and metastasis of tumor cells persistently infected with virus and of human prostatic tumors in athymic nude mice. Proc Natl Acad Sci U S A (1981) 1.34

Mechanism of the antitumour effect of interferon in mice. Nature (1972) 1.17

Hybrid resistance to EL-4 lymphoma cells. I. Characterization of natural killer cells that lyse EL-4 cells and their distinction from marrow-dependent natural killer cells. J Exp Med (1979) 1.16

Tumor necrosis serum induces a serologically distinct population of NK cells. J Exp Med (1979) 1.15

T lymphocytes with promiscuous cytotoxicity. Nature (1976) 1.13

Natural cytotoxic cells against solid tumors in mice. III. A comparison of effector cell antigenic phenotype and target cell recognition structures with those of NK cells. J Immunol (1981) 1.05

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med (1993) 18.56

Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science (1966) 13.12

Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med (1994) 13.11

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity (1999) 12.36

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity (1995) 10.65

Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med (1992) 10.08

Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science (1991) 8.85

Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science (1999) 8.63

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science (2001) 8.31

Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A (1992) 7.74

Genetic systems for mycobacteria. Methods Enzymol (1991) 7.50

Dissection of Mycobacterium tuberculosis antigens using recombinant DNA. Proc Natl Acad Sci U S A (1985) 7.46

Genes for the major protein antigens of the leprosy parasite Mycobacterium leprae. Nature (1985) 6.54

Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science (1991) 6.12

Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science (1993) 5.20

Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature (1995) 5.04

CD1-restricted T cell recognition of microbial lipoglycan antigens. Science (1995) 5.03

An antimicrobial activity of cytolytic T cells mediated by granulysin. Science (1998) 5.02

Lysogeny and transformation in mycobacteria: stable expression of foreign genes. Proc Natl Acad Sci U S A (1988) 4.90

Burden of disease--implications for future research. JAMA (2001) 4.75

Growth of the alveoli and pulmonary arteries in childhood. Thorax (1970) 4.68

Lymphocytes bearing antigen-specific gamma delta T-cell receptors accumulate in human infectious disease lesions. Nature (1989) 4.61

Reactions in vivo and in vitro produced by a soluble substance associated with delayed-type hypersensitivity. Proc Natl Acad Sci U S A (1968) 4.57

Induction of direct antimicrobial activity through mammalian toll-like receptors. Science (2001) 4.46

Selective primary health care: strategies for control of disease in the developing world. V. Leprosy. Rev Infect Dis (1983) 4.40

Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect Immun (1995) 4.28

Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int Immunol (1998) 4.14

Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J Immunol (1999) 3.96

Transfer of delayed-type hypersensitivity. A critical review and experimental study in the guinea pig. Prog Allergy (1967) 3.86

Introduction of foreign DNA into mycobacteria using a shuttle phasmid. Nature (1987) 3.83

Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages. Infect Immun (1993) 3.80

An integrated map of the genome of the tubercle bacillus, Mycobacterium tuberculosis H37Rv, and comparison with Mycobacterium leprae. Proc Natl Acad Sci U S A (1996) 3.78

Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1997) 3.67

In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenesis. Infect Immun (1995) 3.56

Human T-cell clones recognize a major M. leprae protein antigen expressed in E. coli. Nature (1986) 3.51

In vitro approaches to the mechanism of cell-mediated immune reactions. Adv Immunol (1971) 3.49

Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proc Natl Acad Sci U S A (1999) 3.43

Differential effects of cytolytic T cell subsets on intracellular infection. Science (1997) 3.39

Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis. Infect Immun (2000) 3.39

IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol (1995) 3.29

Mutually dependent secretion of proteins required for mycobacterial virulence. Proc Natl Acad Sci U S A (2005) 3.29

TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). J Immunol (1985) 3.18

Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells. Immunity (1995) 3.12

New pathological findings in emphysema of childhood. 1. Polyalveolar lobe with emphysema. Thorax (1970) 3.09

Allelic exchange in Mycobacterium tuberculosis with long linear recombination substrates. J Bacteriol (1996) 2.98

NEDD8 recruits E2-ubiquitin to SCF E3 ligase. EMBO J (2001) 2.94

Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect Immun (1991) 2.77

Cytokine patterns of immunologically mediated tissue damage. J Immunol (1992) 2.72

Insertional mutagenesis and illegitimate recombination in mycobacteria. Proc Natl Acad Sci U S A (1991) 2.69

Arterial changes in the lungs in cirrhosis of the liver--lung spider nevi. N Engl J Med (1966) 2.65

Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid. Nature (1984) 2.63

Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2000) 2.63

Studies on the migration inhibitory factor associated with delayed-type hypersensitivity: cytodynamics and specificity. Transplantation (1967) 2.52

An anti-inflammatory role for gamma delta T lymphocytes in acquired immunity to Mycobacterium tuberculosis. J Immunol (1997) 2.46

Lepromin-induced suppressor cells in patients with leprosy. J Immunol (1979) 2.45

New observations of rat airway epithelium: a quantitative and electron microscopic study. J Anat (1975) 2.45

Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am J Physiol (1979) 2.40

The evolving relation between humans and Mycobacterium tuberculosis. N Engl J Med (1998) 2.39

The Fc receptors of primary and cultured phagocytic cells studied with homogeneous antibodies. J Immunol (1978) 2.38

Nonpeptide ligands for human gamma delta T cells. Proc Natl Acad Sci U S A (1994) 2.33

The effect of continued hypoxia on rat pulmonary arterial circulation. An ultrastructural study. Lab Invest (1978) 2.32

Characterization of antibody-reactive epitopes on the 65-kilodalton protein of Mycobacterium leprae. Infect Immun (1987) 2.30

Genetic relationships among Mycobacterium leprae, Mycobacterium tuberculosis, and candidate leprosy vaccine strains determined by DNA hybridization: identification of an M. leprae-specific repetitive sequence. Infect Immun (1989) 2.29

Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis. Proc Natl Acad Sci U S A (1996) 2.27

Use of in vivo complementation in Mycobacterium tuberculosis to identify a genomic fragment associated with virulence. Infect Immun (1994) 2.26

Microbial glycolipids: possible virulence factors that scavenge oxygen radicals. Proc Natl Acad Sci U S A (1989) 2.21

Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. Proc Natl Acad Sci U S A (2000) 2.20

A novel transposon trap for mycobacteria: isolation and characterization of IS1096. J Bacteriol (1991) 2.20

Pulmonary arterial development during childhood: branching pattern and structure. Thorax (1973) 2.20

Mutation of the principal sigma factor causes loss of virulence in a strain of the Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A (1995) 2.17

A plaque assay for enumerating antigen-sensitive cells in delayed-type hypersensitivity. J Exp Med (1970) 2.15

Rap1 is a potent activation signal for leukocyte function-associated antigen 1 distinct from protein kinase C and phosphatidylinositol-3-OH kinase. Mol Cell Biol (2000) 2.14

A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. Proc Natl Acad Sci U S A (1998) 2.13

New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. Br J Exp Pathol (1976) 2.06

Games parasites play: how parasites evade immune surveillance. Nature (1979) 2.04

Macrophage variants in oxygen metabolism. J Exp Med (1980) 2.04

Structure of the heat shock protein chaperonin-10 of Mycobacterium leprae. Science (1996) 2.03

Migration inhibitory factor associated with delayed-type hypersensitivity. Fed Proc (1990) 2.02

Immunological unresponsiveness in leprosy. Immunol Rev (1984) 2.02

The effects of early childbearing on schooling over time. Fam Plann Perspect (2002) 2.02

Delineation of a human T cell subset responsible for lepromin-induced suppression in leprosy patients. J Immunol (1980) 2.02

Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J Immunol (1993) 2.00

Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination. Proc Natl Acad Sci U S A (1978) 1.97

Interferon-gamma-induced transcriptional activation is mediated by protein kinase C. Proc Natl Acad Sci U S A (1988) 1.97

The major native proteins of the leprosy bacillus. J Biol Chem (1990) 1.96

Tuberculosis. Back to a frightening future. Nature (1992) 1.95

The bHLH gene Hes1 is essential for expansion of early T cell precursors. Genes Dev (1999) 1.95

An organ culture study of the effect of drugs on the secretory activity of the human bronchial submucosal gland. Clin Sci (1972) 1.95

Identification of differentially expressed mRNA in prokaryotic organisms by customized amplification libraries (DECAL): the effect of isoniazid on gene expression in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1998) 1.94

Mitotic rates, goblet cell increase and histochemical changes in mucus in rat bronchial epithelium during exposure to sulphur dioxide. J Pathol Bacteriol (1968) 1.94

A major T cell antigen of Mycobacterium leprae is a 10-kD heat-shock cognate protein. J Exp Med (1992) 1.93

Auxotrophic vaccines for tuberculosis. Nat Med (1996) 1.89

Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction. Clin Exp Immunol (1993) 1.88

Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results. Lancet (1992) 1.87

Lung hypoplasia in congenital diaphragmatic hernia. A quantitative study of airway, artery, and alveolar development. Br J Surg (1971) 1.87

Histochemical types of acidic glycoprotein produced by mucous cells of the tracheobronchial glands in man. J Pathol (1969) 1.86

Rap1 GTPase-activating protein SPA-1 negatively regulates cell adhesion. J Biol Chem (1999) 1.86

The separation and characterization of bronchial glycoproteins by density-gradient methods. Biochem J (1977) 1.86

Mycobacterial infection of macrophages results in membrane-permeable phagosomes. Proc Natl Acad Sci U S A (1999) 1.84

Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization. J Exp Med (1989) 1.82